Top 3 Largest IPOs Scheduled for October 2023
5 minutes for reading
WeBuy Global Ltd., Healthy Green Group Holding, and CardieX Ltd. are on the Top 3 list of companies with the largest IPOs by market capitalisation, scheduled for October 2023. In this article, we will explore the business models of these issuers, examine the outlook for their target market and the details of their scheduled initial public offerings. We will also look at the financial position of these companies, including their strengths and weaknesses.
1. IPO of WeBuy Global Ltd. – 218.92 million USD
Year of registration: 2019
Registered in: Cayman Islands
Headquarters: Singapore
Sector: technology
Date of IPO: 06.10.2023
Exchange: NASDAQ
Ticker: WBUY
WeBuy Global Ltd. has developed an online platform for joint shopping, where members of messenger communities collaborate for joint or shared purchases.
Investments raised (as at 31.12.2022) amount to 16 million USD.
The main investors are Wavemaker Pacific 3, L.P., Rocket Internet Capital Partners ii Scs, TLCW VENTURES PTE. LTD, GBUY GLOBAL LTD, and TLCW VENTURES PTE. LTD.
WeBuy Global market assessment
According to a report by Statista, the social e-commerce market in Southeast Asia, where WeBuy Global operates, was valued at 20 billion USD in 2022 and is projected to reach 34.5 billion USD by 2026. The compound annual projected growth rate from 2023 to 2026 inclusive is 20%.
Financial performance of WeBuy Global
Revenue for 2022: 44.56 million USD, +99.9%
Net loss for 2022: 6.7 million USD
Net cash flow (as at 31.03.2023): −4.1 million USD
Cash and cash equivalents (as at 31.12.2022): 1.6 million USD
Liabilities (as at 31.12.2022): 10.8 million USD
Strengths and weaknesses of WeBuy Global
Strengths:
- A promising target market
- Decreasing net loss
- Increasing revenue
- An effective marketing strategy
Weaknesses:
- Intense competition
- The issuer operates in markets of countries with different legislation, which increases dependence on regulatory authorities
- Absence of dividend payment plans
Details of the WeBuy Global IPO
Underwriter: EF Hutton, division of Benchmark Investments, LLC
Volume of IPO offering: 3.5 million ordinary shares
Average price: 4.25 USD
Gross proceeds: 14.87 million USD
Expected amount of capitalisation at the time of the IPO: 218.92 million USD
Potential P/S: 4.91
Average P/S value in the industry: 1.63
2. IPO of Healthy Green Group Holding – 73.9 million USD
Year of registration: 1999
Registered in: Cayman Islands
Headquarters: Hong Kong
Sector: consumer protection
Date of IPO: 19.10.2023
Exchange: NYSE
Ticker: GDD
Healthy Green Group Holding is engaged in the sale of natural food products through its retail chain in residential areas in Hong Kong. The company also accepts online orders.
Investments raised (as at 30.06.2022): 1.4 million USD
The main investors are WKW Investment Limited and CFT Investment Holding Limited.
Healthy Green Group market assessment
According to a report by ReportLinker, the food products market in Hong Kong, where Healthy Green Group operates, was valued at 18.3 billion USD in 2020. The compound annual growth rate from 2016 to 2020 inclusive was 1.1%.
Financial performance of Healthy Green Group
Revenue for 2022: 20.73 million USD, 1.2%
Net profit for 2022: 0.7 million USD
Net cash flow (as at 30.06.2023): −0.82 million USD
Cash and cash equivalents (as at 30.06.2022): 0.23 million USD
Liabilities (as at 31.12.2022): 12.6 million USD
Strengths and weaknesses of Healthy Green Group
Strengths:
- A promising target market
- Net profit
- Increasing revenue
- A stable market share
Weaknesses:
- Intense competition
- Exposure to new coronavirus restrictions
- Absence of dividend payment plans
Details of the Healthy Green Group IPO
Underwriter: EF Hutton, division of Benchmark Investments, LLC
Volume of IPO offering: 2.0 million ordinary shares
Average price: 6.5 USD
Gross proceeds: 13 million USD
Expected amount of capitalisation at the time of the IPO: 73.9 million USD
Potential P/S: 3.56
Average P/S value in the industry: 0.40
3. CardieX Ltd – 73.9 million USD
Year of registration: 1994
Registered in: Australia
Headquarters: Sydney
Sector: healthcare
Date of IPO: 05.10.2023
Exchange: NASDAQ
Ticker: CDEX
CardieX Ltd develops medical devices for monitoring and treatment of various diseases such as hypertension, cardiovascular diseases, etc. The company’s product line includes devices for monitoring all basic human health parameters.
Investments raised (as at 30.06.2022): 1.55 million USD
The main investor is C2 Ventures Pty Limited.
CardieX market assessment
According to a report by Grand View Research, the global market of digital medical devices, where CardieX operates, was valued at 107.86 billion USD in 2022 and could reach 667.8 billion USD by 2030. The compound annual growth rate from 2023 to 2030 inclusive will be 25.6%.
Financial performance of CardieX
Revenue for 2022 (as at 30.06.2022): 2.95 million USD, 21%
Net profit for 2022: 8.7 million USD
Net cash flow (as at 30.06.2023): −4.62 million USD
Cash and cash equivalents (as at 31.12.2022): 1.68 million USD
Liabilities (as at 31.12.2022): 6.53 million USD
Strengths and weaknesses of CardieX
Strengths:
- A promising target market
- Increasing revenue
- Proprietary technology practices
Weaknesses:
- Intense competition
- The necessity to raise funds in the future
- Absence of dividend payment plans
Details of the CardieX IPO
Underwriter: Roth Capital Partners, LLC
Volume of IPO offering: 1.33 million ADS
Average price: 7.4 USD
Gross proceeds: 9.84 million USD
Expected amount of capitalisation at the time of the IPO: 73.9 million USD
Potential P/S: 6.8
Average P/S value in the industry: 3.7
Summary
WeBuy Global Ltd., Healthy Green Group Holding, and CardieX Ltd. intend to go public in October. Their IPOs are expected to be the largest placements this month in terms of anticipated market capitalisation. The first one of these companies operates in the technology sector, the second one is associated with the consumer protection sector and the third one is involved in the healthcare industry.
* – Past performance is not a reliable indicator of future results or future performance.
The material presented and the information contained herein is for information purposes only and in no way should be considered as the provision of investment advice for the purposes of Investment Firms Law 87(I)/2017 of the Republic of Cyprus or any other form of personal advice or recommendation, which relates to certain types of transactions with certain types of financial instruments.